Prediction models for the risk of new-onset hypertension in ethnic Chinese in Taiwan

Journal of Human Hypertension

Volumn 25, Issue 5, 2011, Pages 294-303

  Chien, K L ^a,b   Hsu, H C ^b   Su, T C ^b   Chang, W T ^b   Sung, F C ^c   Chen, M F ^b   Lee, Y T ^b,c  

^a NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^b NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^c CHINA MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

cohort study; community screening; prediction model

Indexed keywords

GLUCOSE; URIC ACID;

ADULT; AGE; AGED; ARTICLE; BLOOD CELL COUNT; BLOOD GLUCOSE MONITORING; BODY MASS; CARDIOVASCULAR RISK; CHEMICAL ANALYSIS; CHINESE; COHORT ANALYSIS; CONFIDENCE INTERVAL; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; DIET RESTRICTION; ETHNIC GROUP; FEMALE; HIGH RISK POPULATION; HUMAN; HUMAN EXPERIMENT; HYPERTENSION; MALE; NORMAL HUMAN; PROSPECTIVE STUDY; RECEIVER OPERATING CHARACTERISTIC; RISK ASSESSMENT; SEX DIFFERENCE; SYSTOLIC BLOOD PRESSURE; TAIWAN; URIC ACID BLOOD LEVEL;

ADULT; AGED; AREA UNDER CURVE; ASIAN CONTINENTAL ANCESTRY GROUP; BLOOD PRESSURE; BODY MASS INDEX; COHORT STUDIES; FEMALE; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; MODELS, STATISTICAL; PROSPECTIVE STUDIES; RISK FACTORS; TAIWAN;

EID: 79954845059     PISSN: 09509240     EISSN: 14765527     Source Type: Journal    
DOI: 10.1038/jhh.2010.63     Document Type: Article

References (41)

1. Mancia G, De Backer G, Dominiczak A, Cifkova R, Fagard R, Germano G et al. 2007 Guidelines for the management of arterial hypertension: the Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). Eur Heart J 2007; 28: 1462-1536.
2. Wang NY, Young JH, Meoni LA, Ford DE, Erlinger TP, Klag MJ. Blood pressure change and risk of Hypertension associated with parental hypertension: the Johns Hopkins Precursors Study. Arch Intern Med 2008; 168: 643-648. (Pubitemid 351468399)
3. Janghorbani M, Amini M. Hypertension in type 2 diabetes mellitus in Isfahan, Iran: incidence and risk factors. Diabetes Res Clin Pract 2005; 70: 71-80. (Pubitemid 41207650)
4. Parikh NI, Pencina MJ, Wang TJ, Benjamin EJ, Lanier KJ, Levy D et al. A risk score for predicting near-term incidence of hypertension: the Framingham Heart Study. Ann Intern Med 2008; 148: 102-110. (Pubitemid 351651553)
5. Sesso HD, Buring JE, Chown MJ, Ridker PM, Gaziano JM. A prospective study of plasma lipid levels and hypertension in women. Arch Intern Med 2005; 165: 2420-2427. (Pubitemid 41640856)
6. Mellen PB, Bleyer AJ, Erlinger TP, Evans GW, Nieto FJ, Wagenknecht LE et al. Serum uric acid predicts incident hypertension in a biethnic cohort: the athero-sclerosis risk in communities study. Hypertension 2006; 48: 1037-1042. (Pubitemid 44772705)
7. Sesso HD, Buring JE, Rifai N, Blake GJ, Gaziano JM, Ridker PM. C-reactive protein and the risk of develop-ing hypertension. JAMA 2003; 290: 2945-2951. (Pubitemid 37505526)
8. Pearson TA, LaCroix AZ, Mead LA, Liang KY The prediction of midlife coronary heart disease and hyper-tension in young adults: the Johns Hopkins multiple risk equations. Am J Prevent Med 1990; 6: 23-28. (Pubitemid 20337818)
9. Wang TJ, Gona P, Larson MG, Levy D, Benjamin EJ, Tofler GH et al. Multiple biomarkers and the risk of incident hypertension. Hypertension 2007; 49: 432-438.
10. Paynter NP, Cook NR, Everett BM, Sesso HD, Buring JE, Ridker PM. Prediction of incident hypertension risk in women with currently normal blood pressure. Am J Med 2009; 122: 464-471.
11. Kivimaki M, Batty GD, Singh-Manoux A, Ferrie JE, Tabak AG, Jokela M et al. Validating the Framingham Hypertension Risk Score: results from the Whitehall II study. Hypertension 2009; 54: 496-501.
12. Krishnan E, Kwoh CK, Schumacher HR, Kuller L. Hyperuricemia and incidence of hypertension among men without metabolic syndrome. Hypertension 2007; 49: 298-303. (Pubitemid 46143005)
13. Sundstrom J, Sullivan L, D'Agostino RB, Levy D, Kannel WB, Vasan RS. Relations of serum uric acid to longitudinal blood pressure tracking and hypertension incidence. Hypertension 2005; 45: 28-33. (Pubitemid 40066409)
14. Schulze MB, Shai I, Manson JE, Li T, Rifai N, Jiang R et al. Joint role of non-HDL cholesterol and glycated haemoglobin in predicting future coronary heart disease events among women with type 2 diabetes. Diabetologia 2004; 47: 2129-2136. (Pubitemid 40174685)
15. Chien K, Cai T, Hsu H, Su T, Chang W, Chen M et al. A prediction model for type 2 diabetes risk among Chinese people. Diabetologia 2009; 52: 443-450.
16. Chien KL, Hsu HC, Sung FC, Su TC, Chen MF, Lee YT. Incidence of hypertension and risk of cardiovascular events among ethnic Chinese: report from a commu-nity-based cohort study in Taiwan. J Hypertens 2007; 25: 1355-1361.
17. Lee YT, Lin RS, Sung FC, Yang CY, Chien KL, Chen WJ et al. Chin-Shan Community Cardiovascular Cohort in Taiwan: baseline data and five-year follow-up morbidity and mortality. Clin Epidemiol 2000; 53: 836-846.
18. Chien KL, Hsu HC, Su TC, Chen MF, Lee YT, Hu FB. Apolipoprotein B and non-high-density lipoprotein cholesterol and risk of coronary heart disease in Chinese. J Lipid Res 2007; 48: 2499-2505. (Pubitemid 350058761)
19. Chien KL, Hsu HC, Chen PC, Su TC, Chang WT, Chen MF et al. Urinary sodium and potassium excretion and risk of hypertension in Chinese: report from a community-based cohort study in Taiwan. J Hypertens 2008; 26: 1750-1756.
20. Chien KL, Lee YT, Sung FC, Su TC, Hsu HC, Lin RS. Lipoprotein (a) level in the population in Taiwan: relationship to sociodemographic and atherosclerotic risk factors. Atherosclerosis 1999; 143: 267-273.
21. Chien KL, Hsu HC, Sung FC, Su TC, Chen MF, Lee YT. Hyperuricemia as a risk factor on cardiovascular events in Taiwan: the Chin-Shan Community Cardiovascular Cohort Study. Atherosclerosis 2005; 183: 147-155.
22. Fossati P, Prencipe L, Berti G. Use of 3,5-dichloro-2- hydroxybenzenesulfonic acid/4-aminophenazone chromogenic system in direct enzymic assay of uric acid in serum and urine. Clin Chem 1980; 26: 227-231. (Pubitemid 10164452)
23. Chien KL, Chen MF, Hsu HC, Chang WT, Su TC, Lee YT et al. plasma uric acid and the risk of type 2 diabetes in a Chinese community. Clin Chem 2008; 54: 310-316.
24. Schulze MB, Hoffmann K, Boeing H, Linseisen J, Rohrmann S, Mohlig M et al. An accurate risk score based on anthropometric, dietary, and lifestyle factors to predict the development oftype 2 diabetes. Diabetes Care 2007; 30: 510-515. (Pubitemid 46354326)
25. Sullivan LM, Massaro JM, D'Agostino Sr RB. Presenta-tion of multivariate data for clinical use: the Framing-ham Study risk score functions. Stat Med 2004; 23: 1631-1660. (Pubitemid 38660414)
26. Hosmer Jr DW, Lemeshow S. The multiple logistic regression model. In: David W Hosmer Jr, Stanley Lemeshow (eds). Applied Logistic Regression. 1st edn. John Wiley & Sons: New York, 1989, pp 25-37.
27. McGeechan K, Macaskill P, Irwig L, Liew G, Wong TY Assessing new biomarkers and predictive models for use in clinical practice: a clinician's guide. Arch Intern Med 2008; 168: 2304-2310.
28. Hanley JA, McNeil BJ. A method of comparing the areas under receive operating characteristic curves derived from the same cases. Radiology 1983; 148: 839-843. (Pubitemid 13033817)
29. DeLong ER, DeLong DM, Clarke-Pearson DL. Compar-ing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach. Biometrics 1988; 44: 837-845.
30. Cook NR. Use and misuse of the receiver operating characteristic curve in risk prediction. Circulation 2007; 115: 928-935. (Pubitemid 46294733)
31. Efron B, Tibshirani RJ. An introduction to the Bootstrap. Chapman & Hall/CRC: New York, 1994. p 456.
32. Pencina MJ, D' Agostino Sr RB, D' Agostino Jr RB, Vasan RS. Evaluating the added predictive ability of a new marker: from area under the ROC curve to reclassification and beyond. Stat Med 2008; 27: 157-172. (Pubitemid 351193639)
33. Bland JM, Altman DG. Comparing methods of measurement: why plotting difference against standard method is misleading. Lancet 1995; 346: 1085-1087.
34. D'Agostino Sr RB, Vasan RS, Pencina MJ, Wolf PA, Cobain M, Massaro JM et al. General cardiovascular risk profile for use in primary care: the Framingham Heart Study. Circulation 2008; 117: 743-753. (Pubitemid 351640675)
35. Chen PC, Sung FC, Su TC, Chien KL, Hsu HC, Lee YT. Two-year change in body mass index and subsequent risk of hypertension among men and women in a Taiwan community. J Hypertens 2009; 27: 1370-1376.
36. Czernichow S, Mennen L, Bertrais S, Preziosi P, Hercberg S, Oppert JM. Relationships between changes in weight and changes in cardiovascular risk factors in middle-aged French subjects: effect of dieting. Int J Obes Relat Metab Disord 2002; 26: 1138-1143.
37. Apostolides AY, Cutter G, Daugherty SA, Detels R, Kraus J, Wassertheil-Smoller S et al. Three-year incidence of hypertension in thirteen US commu-nities. On behalf of the Hypertension Detection and Follow-up Program cooperative group. PrevMed 1982; 11: 487-499.
38. Vasan RS, Beiser A, Seshadri S, Larson MG, Kannel WB, D'Agostino RB et al. Residual lifetime risk for developing hypertension in middle-aged women and men: the Framingham Heart Study. Jama 2002; 287: 1003-1010. (Pubitemid 34252058)
39. Franklin SS, Gustin IV W, Wong ND, Larson MG, Weber MA, Kannel WB et al. Hemodynamic patterns of age-related changes in blood pressure. The Framing-ham Heart Study. Circulation 1997; 96: 308-315. (Pubitemid 27298437)
40. Perlstein TS, Gumieniak O, Williams GH, Sparrow D, Vokonas PS, Gaziano M et al. Uric acid and the development of hypertension: the normative aging study. Hypertension 2006; 48: 1031-1036. (Pubitemid 44772704)
41. Forman JP, Stampfer MJ, Curhan GC. Diet and lifestyle risk factors associated with incident hypertension in women. Jama 2009; 302: 401-411.